Skip to main content

Table 1 Patient characteristics of the FIDELIO-DKD ITT population [13]

From: Cost-effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands

Parameter

Value at baseline (95% CI)

Age

65.6 (47.8–83.4)

Proportion male (%)

70.2% (69.0–71.4%)

Proportion with CKD 1/2 (%)

11.6%a

Proportion with CKD 3a/b (%)

76.2%a

Proportion with CKD 4 (%)

12.3%adistri

Proportion with CKD 5 (%)

0.0%

Proportion with ESKD and dialysis (%)

0.0%

Proportion with ESKD and transplantation (%)

0.0%

  1. CI confidence interval, CKD chronic kidney disease, ESKD end-stage kidney disease
  2. aProportions of CKD stage are dependent on each other and were varied in sensitvity analyses by using a Dirichlet distribution